Testing effectiveness (Phase 2)Study completedNCT01895361
What this trial is testing
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
Who this might be right for
Sickle Cell Disease
Reprixys Pharmaceutical Corporation 198